Article
Maternally administered naltrexone and its major active metabolite 6β-naltrexol transport across the placental barrier <i>in vitro</i>
2020-04-18
Abstract excerpt
Opioid use disorder (OUD) has become a growing concern in the U.S. and has been a dominant presence among pregnant women, resulting in an unprecedented amount of prescription medications, particularly naltrexone (NTX), prescribed for pregnant women. Because of unknown potential harm that NTX can impose on the fetus and its premature brain, the needs for safety and regulation of NTX are still undetermined. To addre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d1050851-ba69-5262-87ec-2c7e6555c7c2
- DOI
- 10.1101/2020.04.16.045229
